Cellular reprogramming: a new approach to modelling Parkinson's disease.

Cellular reprogramming: a new approach to modelling Parkinson's disease.

iPSCs (induced pluripotent stem cells) offer an unparalleled opportunity to generate and study physiologically relevant cell types in culture. iPSCs can be generated by reprogramming almost any somatic cell type using pluripotency factors such as Oct4, SOX2, Nanog and Klf4. By reprogramming cells fr...

Volledige beschrijving

Bibliografische gegevens
Hoofdauteurs:	Hartfield, E, Fernandes, H, Vowles, J, Cowley, S, Wade-Martins, R
Formaat:	Journal article
Taal:	English
Gepubliceerd in:	2012

Gelijkaardige items

Physiological characterisation of human iPS-derived dopaminergic neurons
door: Hartfield, E, et al.
Gepubliceerd in: (2014)

Physiological characterisation of human iPS-derived dopaminergic neurons
door: Hartfield, E, et al.
Gepubliceerd in: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool.
door: Badger, J, et al.
Gepubliceerd in: (2014)

Parkinson's disease in a dish - Using stem cells as a molecular tool
door: Badger, J, et al.
Gepubliceerd in: (2014)

Cellular α-synuclein pathology is associated with bioenergetic dysfunction in Parkinson's iPSC-derived dopamine neurons
door: Zambon, F, et al.
Gepubliceerd in: (2019)

Protein-protein interaction networks identify targets which rescue the MPP+ cellular model of Parkinson's disease
door: Keane, H, et al.
Gepubliceerd in: (2015)

Variant U1 snRNAs are implicated in human pluripotent stem cell maintenance and neuromuscular disease.
door: Vazquez-Arango, P, et al.
Gepubliceerd in: (2016)

Physiological characterisation of human iPS-derived dopaminergic neurons.
door: Elizabeth M Hartfield, et al.
Gepubliceerd in: (2014-01-01)

Transcriptomic profiling of purified patient-derived dopamine neurons identifies convergent perturbations and therapeutics for Parkinson's disease.
door: Sandor, C, et al.
Gepubliceerd in: (2017)

Cell reprogramming therapy for Parkinson’s disease
door: Wenjing Dong, et al.
Gepubliceerd in: (2024-01-01)

ER stress and autophagic perturbations lead to elevated extracellular α-Synuclein in GBA-N370S Parkinson's iPSC-derived dopamine neurons
door: Fernandes, H, et al.
Gepubliceerd in: (2016)

Cellular reprogramming for understanding and treating human disease.
door: Riya Rajan Kanherkar, et al.
Gepubliceerd in: (2014-11-01)

Neuroprotective Effects of Cryptotanshinone in a Direct Reprogramming Model of Parkinson’s Disease
door: Joo-Eun Lee, et al.
Gepubliceerd in: (2020-08-01)

Epigenetic Dynamics in Reprogramming to Dopaminergic Neurons for Parkinson's Disease
door: Byounggook Cho, et al.
Gepubliceerd in: (2024-11-01)

Astrocyte-to-neuron reprogramming and crosstalk in the treatment of Parkinson's disease
door: Yiming Wang, et al.
Gepubliceerd in: (2023-08-01)

Commentary: Parkinson disease-linked GBA mutation effects reversed by molecular chaperones in human cell and fly models
door: Fernandes, H, et al.
Gepubliceerd in: (2017)

Are rodent models of Parkinson's disease behaving as they should?
door: Vingill, S, et al.
Gepubliceerd in: (2017)

Cellular Reprogramming and Its Potential Application in Alzheimer’s Disease
door: Chao Zhou, et al.
Gepubliceerd in: (2022-04-01)

Network pharmacology of the MPP+ cellular model of Parkinson’s disease
door: Keane, H
Gepubliceerd in: (2015)

RNA sequencing reveals MMP2 and TGFB1 downregulation in LRRK2 G2019S Parkinson's iPSC-derived astrocytes
door: Booth, H, et al.
Gepubliceerd in: (2019)

Programming and reprogramming cellular identity
door: Marson, Alexander
Gepubliceerd in: (2008)

Re: Epigenetics of Cellular Reprogramming
door: Fehmi Narter
Gepubliceerd in: (2016-12-01)

Deterministic versus stochastic model of reprogramming: new evidence from cellular barcoding technique
door: Anastasia M. Yunusova, et al.
Gepubliceerd in: (2017-01-01)

Convergent pathways in Parkinson’s disease
door: Cherubini, M, et al.
Gepubliceerd in: (2017)

Advances in Cellular Reprogramming-Based Approaches for Heart Regenerative Repair
door: Xingyu He, et al.
Gepubliceerd in: (2022-12-01)

Potential cellular and regenerative approaches for the treatment of Parkinson&rsquo;s disease
door: Emma L Lane, et al.
Gepubliceerd in: (2008-08-01)

Cellular Reprogramming toward the Erythroid Lineage
door: Laura J. Norton, et al.
Gepubliceerd in: (2011-01-01)

Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes
door: Lang, C, et al.
Gepubliceerd in: (2018)

Epigenetic reprogramming shapes the cellular landscape of schwannoma
door: S. John Liu, et al.
Gepubliceerd in: (2024-01-01)

Epigenetic determinants of cellular differentiation, transcriptional reprogramming, and human disease
door: Nguyen, Khoi Thien.
Gepubliceerd in: (2021)

The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming
door: Bharathi Suresh, et al.
Gepubliceerd in: (2016-01-01)

Dynamical systems theory of cellular reprogramming
door: Yuuki Matsushita, et al.
Gepubliceerd in: (2022-04-01)

Cellular programming and reprogramming - Methods and protocols
door: CarloAlberto Redi
Gepubliceerd in: (2010-12-01)

Implications of Cellular Aging in Cardiac Reprogramming
door: Fabiana Passaro, et al.
Gepubliceerd in: (2018-04-01)

Neuroregeneration using in vivo cellular reprogramming
door: Tu Nguyen, et al.
Gepubliceerd in: (2017-01-01)

The role of astrocyte dysfunction in Parkinson's disease pathogenesis
door: Booth, H, et al.
Gepubliceerd in: (2017)

Induced pluripotent stem cell (iPSC)-derived dopaminergic models of Parkinson's disease.
door: Beevers, J, et al.
Gepubliceerd in: (2013)

Parkinson’s Disease in a Dish: What Patient Specific-Reprogrammed Somatic Cells Can Tell Us about Parkinson’s Disease, If Anything?
door: J. Drouin-Ouellet, et al.
Gepubliceerd in: (2012-01-01)

Exploring the Mitochondrial Degradome by the TAILS Proteomics Approach in a Cellular Model of Parkinson’s Disease
door: Marta Lualdi, et al.
Gepubliceerd in: (2019-07-01)

New roles of glycosaminoglycans in α-synuclein aggregation in a cellular model of Parkinson disease.
door: Sonia Lehri-Boufala, et al.
Gepubliceerd in: (2015-01-01)